Podchaser Logo
Home
Managing Immunotherapy-Related Adverse Events during Adjuvant Treatment for Resectable Melanoma

Managing Immunotherapy-Related Adverse Events during Adjuvant Treatment for Resectable Melanoma

Released Friday, 26th April 2024
Good episode? Give it some love!
Managing Immunotherapy-Related Adverse Events during Adjuvant Treatment for Resectable Melanoma

Managing Immunotherapy-Related Adverse Events during Adjuvant Treatment for Resectable Melanoma

Managing Immunotherapy-Related Adverse Events during Adjuvant Treatment for Resectable Melanoma

Managing Immunotherapy-Related Adverse Events during Adjuvant Treatment for Resectable Melanoma

Friday, 26th April 2024
Good episode? Give it some love!
Rate Episode

Unlock Episode Insights with

Podchaser Logo PRO

Reach • Demographics • Contacts • More

Pro Features

Audience & Reach for Managing Immunotherapy-Related Adverse Events during Adjuvant Treatment for Resectable Melanoma

See a breakdown of Audience & Reach for Managing Immunotherapy-Related Adverse Events during Adjuvant Treatment for Resectable Melanoma

Unlock Episode Audience & Reach with Podchaser Pro

Brand Safety for Managing Immunotherapy-Related Adverse Events during Adjuvant Treatment for Resectable Melanoma

See Brand Safety for Managing Immunotherapy-Related Adverse Events during Adjuvant Treatment for Resectable Melanoma

Unlock Episode Brand Safety with Podchaser Pro

Ad Rate Card of ReachMD CME

How much does it cost to advertise on ReachMD CME?

PlacementCost
Pre-rollAds played before an episode.
Mid-rollAds played during an episode.
Post-rollAds played after an episode.

Frequently Asked Questions about ReachMD CME

Unlock more with Podchaser Pro

  • Audience Insights
  • Contact Information
  • Demographics
  • Charts
  • Sponsor History
  • and More!
Pro Features